Thursday, June 25, 2026
NewsezeNews with Rewards · Earn while you read
+5 credits / query
medicine

Can GLP-1 Drugs Like Ozempic Really Change Your Sense of Smell and Taste?

Newseze Wire·Thu, Jun 25, 6:09 PMWire: Healthline
Open original source Read full story (in-site)
Can GLP-1 Drugs Like Ozempic Really Change Your Sense of Smell and Taste?

Some GLP-1 users report changes in their taste and smell, according to a new study. Tatsiana Volkava/Getty Images Researchers report that GLP-1 drugs used to treat type 2 diabetes may impair a person’s sense of taste and smell.

Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.

Newseze Analysis100 words · original commentary · full read loading…
Some GLP-1 users report changes in their taste and smell, according to a new study. Tatsiana Volkava/Getty Images Researchers report that GLP-1 drugs used to treat type 2 diabetes may impair a person’s sense of taste and smell. The story falls into Newseze's medicine desk and is being actively tracked by our editorial team. Calm framing, primary-source references, and respectful tone — every Newseze story is scored for drama and conspiracy before it reaches you. Worth knowing: Newseze refreshes its newsroom every hour and flags fast-moving local and breaking news as it develops. Watch this page for updates. Reporting: Healthline.
Ask Us · Any Story, Any AnswerBe the first to ask

Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.

No questions yet. Be the first.

Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.

Related stories

Intermittent Fasting Aids Weight Loss, With a Surprising Psychological Benefit
MEDICINEtrust 78
Intermittent Fasting Aids Weight Loss, With a Surprising Psychological Benefit

Why it mattersResearchers compared intermittent fasting with calorie counting and found that people following fasting protocols thought about food less often. Anchiy/Getty Images A recent study found that people who bounce from one di…

Researchers compared intermittent fasting with calorie counting and found that people following fasting protocols thought about food less often. Anchiy/Getty Im…

ChellaBy Chella·5h ago
WireHealthline
Full Analysis Comment PostRead →
EMT Revives Knicks Fan With Narcan as FDA Expands Access to the Medication
MEDICINETrending Righttrust 69
EMT Revives Knicks Fan With Narcan as FDA Expands Access to the Medication

Why it mattersNEW YORK, NEW YORK – JUNE 18: Fans cheer for the New York Knicks as a float with Karl-Anthony Towns and teammates pass by during the New York Knicks Championship ticker tape parade and victory rally celebrating win…

NEW YORK, NEW YORK – JUNE 18: Fans cheer for the New York Knicks as a float with Karl-Anthony Towns and teammates pass by during the New York Knicks Champ…

ChellaBy Chella·2d ago
WireHealthline
Full Analysis Comment PostRead →
Zepbound vs. Wegovy: Which GLP-1 Drug Is Best for Weight Loss?
MEDICINEtrust 75
Zepbound vs. Wegovy: Which GLP-1 Drug Is Best for Weight Loss?

Why it mattersResearchers say that GLP-1 drugs containing tirzepatide (Zepbound, Mounjaro) may lead to greater weight loss. Image Credit: Tatsiana Volkava/Getty Images A meta-analysis found that one type of GLP-1 medication may be mor…

Researchers say that GLP-1 drugs containing tirzepatide (Zepbound, Mounjaro) may lead to greater weight loss. Image Credit: Tatsiana Volkava/Getty Images A meta…

ChellaBy Chella·12h ago
WireHealthline
Full Analysis Comment PostRead →
GLP-1s for $50 a Month? 14 Million Medicare Recipients May Be Eligible
MEDICINEtrust 78
GLP-1s for $50 a Month? 14 Million Medicare Recipients May Be Eligible

Why it mattersAn estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials announced the launch of a Medicare GLP-1 Bridge pilot program…

An estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials a…

ChellaBy Chella·1d ago
WireHealthline
Full Analysis Comment PostRead →